Intuitive Surgical (ISRG) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Explore the exciting world of Intuitive Surgical (ISRG -3.12%) with our expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!
Investing in surgical robotics stocks like ISRG, ZBH and STXS can be profitable for investors in 2025.
Intuitive Surgical (ISRG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Robotic surgery has transformed the healthcare sector, improving patient treatment and outcomes. Intuitive Surgical (ISRG 1.63%) builds and sells the da Vinci, a robotic system used for various surgical procedures.
Intuitive Surgical, Inc. (ISRG) concluded the recent trading session at $492.06, signifying a +1.68% move from its prior day's close.
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Intuitive Surgical's ISRG recent device recall for its latest robotic surgery system, da Vinci 5, has been categorized by the FDA as a Class 2 recall, a grade below the most serious Class I recalls.
AI-powered robotics are set to soar in 2025. Key players like NVDA, ISRG, TSLA and PATH lead transformation across healthcare, manufacturing and mobility sectors.
Zacks.com users have recently been watching Intuitive Surgical (ISRG) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Shares of Intuitive Surgical ISRG have declined 16.5% in the past month, with the price currently trading around its 200-day moving average (200-DMA). The price corrected after touching its all-time high of $616 in January, followed by a retest of the psychological level of $600 in February.
I am bullish on Intuitive Surgical, Inc. due to da Vinci 5's advanced capabilities, reducing surgery complications and blood transfusions significantly compared to open surgeries. Intuitive Surgical's da Vinci 5 offers enhanced range of motion, realistic 3D imaging, and reduced operative time, improving surgical outcomes and patient comfort. Despite being overvalued, ISRG's technological advancements and high investor expectations position it well for growth in the minimally invasive surgery market.